Whole-Head Normalization Using Live Z-Scores For Connectivity Training (Part 2)
Archives
All entries, chronologically...
For the past seven years, Widener’s Institute for Graduate Clinical Psychology has provided coursework leading to Board Certification from the Biofeedback Certification International Alliance (BCIA). The program, taught by Celeste De Bease, PhD, BCB-Fellow, BCN-Fellow and by Pam Calvert-Hirt, PsyD, MBA, BCB, has led many of its graduate students to their dissertations on biofeedback, particularly Haya Al-Joudi.
Migraines cost American taxpayers $13 billion in missed work or reduced productivity annually. In a time of job insecurity and financial vulnerability when stress levels are high and incomes are low, crippling migraines are an ever increasing epidemic. For the 28 million Americans who suffer from recurrent migraines, the accepted treatment is pharmacological therapy. Now a alternative treatment known as neurofeedback has been shown to be a viable treatment option with few side effects for those with recurrent migraine headaches.
Most professionals and researchers in the field of neurofeedback are familiar with the now classic neurofeedback study by Barry Sterman entitled, “Electroencephalographic and Behavioral Studies of Monomethyl Hydrazine Toxicity in the Cat.” This is perhaps one of, or the most, important studies to be conducted in neurofeedback. The Journal of Neurotherapy has made this important study available for all. Check the end of this report for a free download link for full-text access.
Author, neurologist, and neuropsychiatrist Werner Van den Bergh, M.D. recently talked with Christopher Fisher, PhD (CEO of this website’s sister company, BMED Press) about his newly released book, “Neurofeedback and State Regulation in ADHD: A Therapy Without Medication” (published by BMED Press).
Gerald Spindel, M.D., host of the “Eye On Health” series, recently interviewed neurofeedback expert Edward Jacobs, PhD. Dr. Jacobs is Board Certified in Neurofeedback (BCN) and practices psychology in southern New Hampshire. Dr. Jacobs, a polished and knowledgeable speaker, provides a balanced overview of neurofeedback and its use in the treatment of various disorders, such as attention deficit hyperactivity disorder (ADHD), substance abuse, and autism. Included in this report is the original, 4-part video interview that spans approximately 45 minutes.
Ambassador to Germany, Dr. Peter Boehm, and the Canadian High Commissioner to Dusseldorf, Leslie Reissner, paid a visit to the Thought Technology Ltd. booth at Medica, where 137,000 visited for 4 days. Included in this announcement is a video interview with Olivier Jean (short track speed skating gold medalist) and Dr. Pierre Beauchamp (sports psychologist) who discuss the use of biofeedback in the 2010 Vancouver Olympics. Although the video is obviously produced by Thought Technology to promote their biofeedback devices, it is actually a very interesting demonstration of the use of biofeedback, including neurofeedback, in professional sports.
In a recently published article in the journal, Applied Psychophysiology and Biofeedback, researchers report that neurofeedback, a form of biofeedback, significantly improves symptoms of fibromyalgia syndrome (FMS). The authors devised a well thought out study that included a total of 36 patients who experienced FMS. Patient were randomly assigned to 1 of 2 groups: 18 in a neurofeedback group and 18 in an Escitalopram (i.e., Lexipro) group.
Earlier this month, National Public Radio (NPR) discussed neurofeedback for pediatric Attention Deficit Hyperactivity Disorder (ADHD) with Katherine Ellison and several university researchers. If Ellison sounds familiar that is because BMED Report featured a review of her recent article in “The New York Times Discusses Heightened Public Attention And Mainstream Research In Neurofeedback.” NPR made available an audio recording and transcript of the original broadcast. Check the end of this report for a link the NPR website.
The book, “Neurofeedback And State Regulation In ADHD: A Therapy Without Medication,” by Werner Van den Bergh, M.D. received official publication on October 25, 2010. This is a timely book in light of the recent finding that “Neurofeedback for ADHD Achieves A ‘Level 5 – Efficacious and Specific’ Efficacy Rating.” Check the end of this report for an exclusive and time limited discount code for BMED Report readers that includes free shipping.
Are you a neurofeedback practitioner? We want to learn more about your thoughts and experiences with neurofeedback therapy (NFT). We are offering to donate ten dollars ($10.00) to the ISNR (International Society for Neurofeedback and Research) Research Fund when you complete a short, 10 minute online survey. Additional details are provided below, including an brief overview of the study and a link to the online survey. All neurotherapists are encouraged to participate.
